386 related articles for article (PubMed ID: 29611103)
1. Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer's Disease.
Gupta S; Yadav K; Mantri SS; Singhal NK; Ganesh S; Sandhir R
Mol Neurobiol; 2018 Dec; 55(12):8916-8935. PubMed ID: 29611103
[TBL] [Abstract][Full Text] [Related]
2. siRNA Mediated GSK3β Knockdown Targets Insulin Signaling Pathway and Rescues Alzheimer's Disease Pathology: Evidence from
Gupta S; Singh V; Ganesh S; Singhal NK; Sandhir R
ACS Appl Mater Interfaces; 2022 Jan; 14(1):69-93. PubMed ID: 34967205
[TBL] [Abstract][Full Text] [Related]
3. Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease.
Park SJ; Kim YH; Nam GH; Choe SH; Lee SR; Kim SU; Kim JS; Sim BW; Song BS; Jeong KJ; Lee Y; Park YI; Lee KM; Huh JW; Chang KT
Int J Mol Sci; 2015 Jan; 16(2):2386-402. PubMed ID: 25622254
[TBL] [Abstract][Full Text] [Related]
4. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of PDE5 attenuates streptozotocin-induced neuroinflammation and tau hyperphosphorylation in a streptozotocin-treated rat model.
Zhu L; Zhang Z; Hou XJ; Wang YF; Yang JY; Wu CF
Brain Res; 2019 Nov; 1722():146344. PubMed ID: 31344367
[TBL] [Abstract][Full Text] [Related]
6. Sodium orthovanadate improves learning and memory in intracerebroventricular-streptozotocin rat model of Alzheimer's disease through modulation of brain insulin resistance induced tau pathology.
Akhtar A; Bishnoi M; Sah SP
Brain Res Bull; 2020 Nov; 164():83-97. PubMed ID: 32784004
[TBL] [Abstract][Full Text] [Related]
7. Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway.
Tokutake T; Kasuga K; Yajima R; Sekine Y; Tezuka T; Nishizawa M; Ikeuchi T
J Biol Chem; 2012 Oct; 287(42):35222-35233. PubMed ID: 22910909
[TBL] [Abstract][Full Text] [Related]
8. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
[TBL] [Abstract][Full Text] [Related]
9. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
10. Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer's disease.
Barilar JO; Knezovic A; Grünblatt E; Riederer P; Salkovic-Petrisic M
J Neural Transm (Vienna); 2015 Apr; 122(4):565-76. PubMed ID: 25503661
[TBL] [Abstract][Full Text] [Related]
11. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.
Knezovic A; Osmanovic-Barilar J; Curlin M; Hof PR; Simic G; Riederer P; Salkovic-Petrisic M
J Neural Transm (Vienna); 2015 Apr; 122(4):577-92. PubMed ID: 25808906
[TBL] [Abstract][Full Text] [Related]
12. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
[TBL] [Abstract][Full Text] [Related]
13. Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach.
Salkovic-Petrisic M; Hoyer S
J Neural Transm Suppl; 2007; (72):217-33. PubMed ID: 17982898
[TBL] [Abstract][Full Text] [Related]
14. BACE1 RNA interference improves spatial memory and attenuates Aβ burden in a streptozotocin-induced tau hyperphosphorylated rat model.
Yu CJ; Liu W; Chen HY; Wang L; Zhang ZR
Cell Biochem Funct; 2014 Oct; 32(7):590-6. PubMed ID: 25230339
[TBL] [Abstract][Full Text] [Related]
15. Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators.
Maurya SK; Mishra J; Abbas S; Bandyopadhyay S
Mol Neurobiol; 2016 Mar; 53(2):968-982. PubMed ID: 25575682
[TBL] [Abstract][Full Text] [Related]
16. Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer's Disease (sAD) Mouse Model.
Latina V; Giacovazzo G; Calissano P; Atlante A; La Regina F; Malerba F; Dell'Aquila M; Stigliano E; Balzamino BO; Micera A; Coccurello R; Amadoro G
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830036
[TBL] [Abstract][Full Text] [Related]
17. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein
Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z
Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814
[TBL] [Abstract][Full Text] [Related]
18. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model.
Zhu L; Hou XJ; Che XH; Zhou TS; Liu XQ; Wu CF; Yang JY
Acta Pharmacol Sin; 2021 Sep; 42(9):1401-1408. PubMed ID: 33277592
[TBL] [Abstract][Full Text] [Related]
19. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.
Israel MA; Yuan SH; Bardy C; Reyna SM; Mu Y; Herrera C; Hefferan MP; Van Gorp S; Nazor KL; Boscolo FS; Carson CT; Laurent LC; Marsala M; Gage FH; Remes AM; Koo EH; Goldstein LS
Nature; 2012 Jan; 482(7384):216-20. PubMed ID: 22278060
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.
Rockenstein E; Torrance M; Adame A; Mante M; Bar-on P; Rose JB; Crews L; Masliah E
J Neurosci; 2007 Feb; 27(8):1981-91. PubMed ID: 17314294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
